Global Cancer Immunotherapy Drug Discovery Outsourcing Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Cancer Immunotherapy Drug Discovery Outsourcing is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Cancer Immunotherapy Drug Discovery Outsourcing market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Cancer Immunotherapy Drug Discovery Outsourcing industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentations:

    By Players:

    • Covance, Inc

    • Explicyte

    • Aquila BioMedical

    • Horizon Discovery Group PLC

    • Crown Bioscience, Inc

    • Promega Corporation

    • HD Biosciences Co, Ltd

    • BPS Bioscience, Inc

    • Genscript Biotech Corporation

    • DiscoverX Corporation

    • Celentyx Ltd

    • ImmunXperts SA

    • Personalis, Inc

    • STC Biologics

    • Molecular Imaging, Inc

    By Types:

    • Monoclonal Antibodies

    • Immunomodulators

    • Oncolytic Viral Therapies and Cancer Vaccines

    • Other

    By End-User:

    • Lung

    • Breast

    • Colorectal

    • Melanoma

    • Prostate

    • Head and Neck

    • Ovarian

    • Pancreatic

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

      • 1.3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Immunomodulators from 2014 to 2026

      • 1.3.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Oncolytic Viral Therapies and Cancer Vaccines from 2014 to 2026

      • 1.3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Lung from 2014 to 2026

      • 1.4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Breast from 2014 to 2026

      • 1.4.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Colorectal from 2014 to 2026

      • 1.4.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Melanoma from 2014 to 2026

      • 1.4.5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Prostate from 2014 to 2026

      • 1.4.6 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Head and Neck from 2014 to 2026

      • 1.4.7 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Ovarian from 2014 to 2026

      • 1.4.8 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Pancreatic from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cancer Immunotherapy Drug Discovery Outsourcing Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer Immunotherapy Drug Discovery Outsourcing by Major Types

      • 3.4.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Monoclonal Antibodies

      • 3.4.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Immunomodulators

      • 3.4.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Oncolytic Viral Therapies and Cancer Vaccines

      • 3.4.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Other

    4 Segmentation of Cancer Immunotherapy Drug Discovery Outsourcing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer Immunotherapy Drug Discovery Outsourcing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Lung

      • 4.4.2 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Breast

      • 4.4.3 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Colorectal

      • 4.4.4 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Melanoma

      • 4.4.5 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Prostate

      • 4.4.6 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Head and Neck

      • 4.4.7 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Ovarian

      • 4.4.8 Market Size and Growth Rate of Cancer Immunotherapy Drug Discovery Outsourcing in Pancreatic

    5 Market Analysis by Major Regions

    • 5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Production Analysis by Major Regions

    • 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Analysis by Major Regions

    • 5.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

    6 Product Commodity of Cancer Immunotherapy Drug Discovery Outsourcing Market in Major Countries

    • 6.1 Top 5 Export Countries in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis

    • 7.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Types

    • 7.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major End-Users

    • 7.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Countries

      • 7.3.1 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 7.3.2 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 7.3.3 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

    8 Europe Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis

    • 8.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Types

    • 8.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major End-Users

    • 8.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Countries

      • 8.3.1 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.2 UK Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.3 France Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.4 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.6 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.7 Belgium Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.8 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.9 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 8.3.10 Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

    9 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis

    • 9.1 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Types

    • 9.2 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Countries

      • 9.3.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 9.3.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 9.3.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 9.3.6 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 10.3.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 10.3.3 Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

      • 10.3.4 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate 

      • 10.3.5 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Covance, Inc

      • 11.1.1 Covance, Inc Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Explicyte

      • 11.2.1 Explicyte Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Aquila BioMedical

      • 11.3.1 Aquila BioMedical Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Horizon Discovery Group PLC

      • 11.4.1 Horizon Discovery Group PLC Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Crown Bioscience, Inc

      • 11.5.1 Crown Bioscience, Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Promega Corporation

      • 11.6.1 Promega Corporation Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 HD Biosciences Co, Ltd

      • 11.7.1 HD Biosciences Co, Ltd Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 BPS Bioscience, Inc

      • 11.8.1 BPS Bioscience, Inc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Genscript Biotech Corporation

      • 11.9.1 Genscript Biotech Corporation Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 DiscoverX Corporation

      • 11.10.1 DiscoverX Corporation Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Celentyx Ltd

      • 11.11.1 Celentyx Ltd Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 ImmunXperts SA

      • 11.12.1 ImmunXperts SA Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Personalis, Inc

      • 11.13.1 Personalis, Inc Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 STC Biologics

      • 11.14.1 STC Biologics Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Molecular Imaging, Inc

      • 11.15.1 Molecular Imaging, Inc Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 122 Figures and 191 Tables)

    • Figure Product Picture

    • Figure Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • Figure Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Immunomodulators from 2014 to 2026

    • Figure Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Oncolytic Viral Therapies and Cancer Vaccines from 2014 to 2026

    • Figure Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Lung from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Breast from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Colorectal from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Melanoma from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Prostate from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Head and Neck from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Ovarian from 2014 to 2026

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth Rate of Pancreatic from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cancer Immunotherapy Drug Discovery Outsourcing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cancer Immunotherapy Drug Discovery Outsourcing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer Immunotherapy Drug Discovery Outsourcing by Different Types from 2014 to 2026

    • Table Consumption Share of Cancer Immunotherapy Drug Discovery Outsourcing by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Immunomodulators

    • Figure Market Size and Growth Rate of Oncolytic Viral Therapies and Cancer Vaccines

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cancer Immunotherapy Drug Discovery Outsourcing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cancer Immunotherapy Drug Discovery Outsourcing by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Lung

    • Figure Market Size and Growth Rate of Breast

    • Figure Market Size and Growth Rate of Colorectal

    • Figure Market Size and Growth Rate of Melanoma

    • Figure Market Size and Growth Rate of Prostate

    • Figure Market Size and Growth Rate of Head and Neck

    • Figure Market Size and Growth Rate of Ovarian

    • Figure Market Size and Growth Rate of Pancreatic

    • Table Global Cancer Immunotherapy Drug Discovery Outsourcing Production by Major Regions

    • Table Global Cancer Immunotherapy Drug Discovery Outsourcing Production Share by Major Regions

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Production Share by Major Regions in 2014

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Production Share by Major Regions in 2018

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Production Share by Major Regions in 2026

    • Table Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Major Regions

    • Table Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Regions

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Regions in 2014

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Regions in 2018

    • Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Regions in 2026

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cancer Immunotherapy Drug Discovery Outsourcing market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Types from 2014 to 2026

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types from 2014 to 2026

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2014

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2018

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2026

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption by End-Users from 2014 to 2026

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users from 2014 to 2026

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2014

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2018

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2026

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Major Countries from 2014 to 2026

    • Table North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2014

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2018

    • Figure North America Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2026

    • Figure United States Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Types from 2014 to 2026

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types from 2014 to 2026

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2014

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2018

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2026

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption by End-Users from 2014 to 2026

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2014

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2018

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2026

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Major Countries from 2014 to 2026

    • Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2014

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2018

    • Figure Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2026

    • Figure Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure France Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Types from 2014 to 2026

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2014

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2018

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2026

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2014

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2018

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2026

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2026

    • Figure China Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandCancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure India Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Consumption Share by Major Countries in 2026

    • Figure GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Covance, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Covance, Inc

    • Figure Sales and Growth Rate Analysis of Covance, Inc

    • Figure Revenue and Market Share Analysis of Covance, Inc

    • Table Product and Service Introduction of Covance, Inc

    • Table Company Profile and Development Status of Explicyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Explicyte

    • Figure Sales and Growth Rate Analysis of Explicyte

    • Figure Revenue and Market Share Analysis of Explicyte

    • Table Product and Service Introduction of Explicyte

    • Table Company Profile and Development Status of Aquila BioMedical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aquila BioMedical

    • Figure Sales and Growth Rate Analysis of Aquila BioMedical

    • Figure Revenue and Market Share Analysis of Aquila BioMedical

    • Table Product and Service Introduction of Aquila BioMedical

    • Table Company Profile and Development Status of Horizon Discovery Group PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Discovery Group PLC

    • Figure Sales and Growth Rate Analysis of Horizon Discovery Group PLC

    • Figure Revenue and Market Share Analysis of Horizon Discovery Group PLC

    • Table Product and Service Introduction of Horizon Discovery Group PLC

    • Table Company Profile and Development Status of Crown Bioscience, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Crown Bioscience, Inc

    • Figure Sales and Growth Rate Analysis of Crown Bioscience, Inc

    • Figure Revenue and Market Share Analysis of Crown Bioscience, Inc

    • Table Product and Service Introduction of Crown Bioscience, Inc

    • Table Company Profile and Development Status of Promega Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Promega Corporation

    • Figure Sales and Growth Rate Analysis of Promega Corporation

    • Figure Revenue and Market Share Analysis of Promega Corporation

    • Table Product and Service Introduction of Promega Corporation

    • Table Company Profile and Development Status of HD Biosciences Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HD Biosciences Co, Ltd

    • Figure Sales and Growth Rate Analysis of HD Biosciences Co, Ltd

    • Figure Revenue and Market Share Analysis of HD Biosciences Co, Ltd

    • Table Product and Service Introduction of HD Biosciences Co, Ltd

    • Table Company Profile and Development Status of BPS Bioscience, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BPS Bioscience, Inc

    • Figure Sales and Growth Rate Analysis of BPS Bioscience, Inc

    • Figure Revenue and Market Share Analysis of BPS Bioscience, Inc

    • Table Product and Service Introduction of BPS Bioscience, Inc

    • Table Company Profile and Development Status of Genscript Biotech Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genscript Biotech Corporation

    • Figure Sales and Growth Rate Analysis of Genscript Biotech Corporation

    • Figure Revenue and Market Share Analysis of Genscript Biotech Corporation

    • Table Product and Service Introduction of Genscript Biotech Corporation

    • Table Company Profile and Development Status of DiscoverX Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DiscoverX Corporation

    • Figure Sales and Growth Rate Analysis of DiscoverX Corporation

    • Figure Revenue and Market Share Analysis of DiscoverX Corporation

    • Table Product and Service Introduction of DiscoverX Corporation

    • Table Company Profile and Development Status of Celentyx Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celentyx Ltd

    • Figure Sales and Growth Rate Analysis of Celentyx Ltd

    • Figure Revenue and Market Share Analysis of Celentyx Ltd

    • Table Product and Service Introduction of Celentyx Ltd

    • Table Company Profile and Development Status of ImmunXperts SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImmunXperts SA

    • Figure Sales and Growth Rate Analysis of ImmunXperts SA

    • Figure Revenue and Market Share Analysis of ImmunXperts SA

    • Table Product and Service Introduction of ImmunXperts SA

    • Table Company Profile and Development Status of Personalis, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Personalis, Inc

    • Figure Sales and Growth Rate Analysis of Personalis, Inc

    • Figure Revenue and Market Share Analysis of Personalis, Inc

    • Table Product and Service Introduction of Personalis, Inc

    • Table Company Profile and Development Status of STC Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of STC Biologics

    • Figure Sales and Growth Rate Analysis of STC Biologics

    • Figure Revenue and Market Share Analysis of STC Biologics

    • Table Product and Service Introduction of STC Biologics

    • Table Company Profile and Development Status of Molecular Imaging, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Molecular Imaging, Inc

    • Figure Sales and Growth Rate Analysis of Molecular Imaging, Inc

    • Figure Revenue and Market Share Analysis of Molecular Imaging, Inc

    • Table Product and Service Introduction of Molecular Imaging, Inc


Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.